Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension.
暂无分享,去创建一个
[1] EN Li-ping,et al. Proceedings of the American Thoracic Society , 2008 .
[2] R. Coulden. State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. , 2006, Proceedings of the American Thoracic Society.
[3] M. Humbert,et al. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. , 2006, Proceedings of the American Thoracic Society.
[4] Nazzareno Galiè,et al. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. , 2006, Proceedings of the American Thoracic Society.
[5] N. Kim. Assessment of operability in chronic thromboembolic pulmonary hypertension. , 2006, Proceedings of the American Thoracic Society.
[6] W. Klepetko,et al. Current and future management of chronic thromboembolic pulmonary hypertension: from diagnosis to treatment responses. , 2006, Proceedings of the American Thoracic Society.
[7] M. Hoeper,et al. Update in pulmonary hypertension 2005. , 2006, American journal of respiratory and critical care medicine.
[8] P. Thistlethwaite,et al. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. , 2006, The Journal of thoracic and cardiovascular surgery.
[9] J. Matsumura,et al. Vena cava filters: why, when, what, how? , 2005, Perspectives in vascular surgery and endovascular therapy.
[10] A. Peacock. Pulmonary hypertension after splenectomy: a consequence of loss of the splenic filter or is there something more? , 2005, Thorax.
[11] T. Welte,et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. , 2005, Chest.
[12] M. Humbert,et al. Splenectomy and chronic thromboembolic pulmonary hypertension , 2005, Thorax.
[13] D. Mccrory,et al. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[14] A. Torbicki,et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. , 2004, Journal of the American College of Cardiology.
[15] R. Naeije,et al. End points in pulmonary arterial hypertension: the way forward , 2004, European Respiratory Journal.
[16] I. Lang. Chronic thromboembolic pulmonary hypertension--not so rare after all. , 2004, The New England journal of medicine.
[17] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[18] W. Klepetko,et al. Chronic thromboembolic pulmonary hypertension: update 2004 , 2004 .
[19] P. Thistlethwaite,et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. , 2003, The Annals of thoracic surgery.
[20] M. Thelen,et al. Pulmonary balloon angioplasty of chronic thromboembolic pulmonary hypertension (CTEPH) in surgically inaccessible cases. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[21] K. Kerr,et al. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. , 2003, Chest.
[22] L. Tavazzi,et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation , 2002, Heart.
[23] K. Kerr,et al. Chronic thromboembolic pulmonary hypertension. , 2001, Clinics in chest medicine.
[24] J. Feinstein,et al. Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension , 2001, Circulation.
[25] P. Friedman,et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.
[26] M. Humbert,et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.
[27] P. Dartevelle,et al. Endothelial nitric oxide synthase function in pig lung after chronic pulmonary artery obstruction. , 2000, American journal of respiratory and critical care medicine.
[28] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[29] C. Pedersen,et al. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. , 2000, The European respiratory journal.
[30] A. Peacock,et al. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. , 2000, The European respiratory journal.
[31] G. Simonneau,et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. , 2000, Archives of internal medicine.
[32] C. Pedersen,et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. , 2000, Experimental lung research.
[33] K. Kerr,et al. Reoperative pulmonary thromboendarterectomy. , 1999, The Annals of thoracic surgery.
[34] D. Badesch,et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[35] P. Flemming,et al. Pulmonary Hypertension after Splenectomy? , 1999, Annals of Internal Medicine.
[36] P. Pellikka,et al. Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases. , 1998, Mayo Clinic proceedings.
[37] L. Rubin,et al. Medical and surgical treatment options for pulmonary hypertension. , 1998, The American journal of the medical sciences.
[38] W. Steinbrich,et al. Pulmonary circulation , 1998, European Radiology.
[39] G. Simonneau,et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] K. Moser,et al. Advances in acute pulmonary embolism and chronic pulmonary hypertension. , 1997, Advances in internal medicine.
[41] S. Rich,et al. Predictors of mortality in pulmonary thromboendarterectomy. , 1996, The Annals of thoracic surgery.
[42] A. Hirsch,et al. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? , 1996, American journal of respiratory and critical care medicine.
[43] L. Greenfield,et al. Current indications for caval interruption: should they be liberalized in view of improving technology? , 1996, Seminars in vascular surgery.
[44] A. Chaouat,et al. The role of thrombosis in severe pulmonary hypertension. , 1996, The European respiratory journal.
[45] K. Oniszh,et al. [Implantation of LGM inferior vena cava filters in patients with chronic pulmonary hypertension during a course of major vessel thromboembolism--observation of 18 patients]. , 1996, Pneumonologia i alergologia polska.
[46] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[47] J. Golden,et al. Do patients with primary pulmonary hypertension develop extensive central thrombi? , 1995, Circulation.
[48] M. Olman,et al. Parallel Analysis of Tissue‐Type Plasminogen Activator and Type 1 Plasminogen Activator Inhibitor in Plasma and Endothelial Cells Derived From Patients With Chronic Pulmonary Thromboemboli , 1994, Circulation.
[49] D. Loskutoff,et al. Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. , 1994, Circulation.
[50] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[51] K. Moser,et al. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. , 1993, Chest.
[52] B. Groves,et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.
[53] R. Michel,et al. Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships. , 1991, Journal of applied physiology.
[54] W. Auger,et al. Chronic major-vessel thromboembolic pulmonary hypertension. , 1990, Circulation.
[55] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[56] J. Alpert,et al. The natural history of pulmonary embolism. , 1984, Clinics in chest medicine.
[57] J. S. Bower,et al. Differentiation of patients with primary and thromboembolic pulmonary hypertension. , 1984, Chest.